Trial Analysis Characterizes SCLC Disease Progression With Durvalumab vs Placebo Sharon Worcester, MA April 03, 2025

https://www.medscape.com/viewarticle/trial-analysis-characterizes-sclc-disease-progression-2025a100081o?ecd=WNL_conf_onc_ELCC-SPON_250420_MSCPEDIT_etid7368804&uac=148436CN&impID=7368804